MA
Mark Alexander Nelson
Independent Non-Executive DirectorDr. Mark Alexander Nelson was Investment Advisor of Focal. Dr. Nelson was an Interim Independent Non-Executive Chair from February 03, 2026 to August 31, 2026 and is Independent Non-Executive Director of Telix Pharmaceuticals Limited from September 17, 2017. Dr. Nelson is Chairman of Caledonia (Private) Investments Us, LLC. Dr. Nelson is Chairman of Caledonia US, LP. Dr. Nelson was Chairman of Caledonia (Private) Investments Pty Limited. Dr. Nelson has Ph.D. from University of Cambridge in 1986, M.P.H from University of Cambridge, B.S. from University of Melbourne.
Positions
- Company NameTelix Pharmaceuticals LimitedStock CodeTLXPositionIndependent Non-Executive DirectorColleagues
- CPChristian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director
- DNDavid N. GillIndependent Non-Executive Chair of the Board
- DSDarren SmithGroup Chief Financial Officer
- DPDarren PattiGroup Chief Operating Officer
- DNDavid N. CadeGroup Chief Medical Officer
- PSPaul SchafferSVP of Research & Development
- JEJann Elizabeth SkinnerIndependent Non-Executive Director
- MEMarie E. McDonaldIndependent Non-Executive Director
